A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer.
Saved in:
| Title: | A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer. |
|---|---|
| Authors: | Dung PVT; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan., Chen WY; Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan., Liu MK; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan., Yeh SD; Department of Urology and Oncology, Taipei Medical University Hospital, Taipei 11031, Taiwan; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; Prostate Center of Excellence, Taipei Medical University Hospital, Taipei 11031, Taiwan., Kajla G; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan., Yeh HL; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan., Chen WH; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan., Jiang KC; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan., Li HR; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan., Chen CS; School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02215-5450, USA., Wen YC; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei 11031, Taiwan. Electronic address: 95207@w.tmu.edu.tw., Liu YN; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan; Prostate Center of Excellence, Taipei Medical University Hospital, Taipei 11031, Taiwan. Electronic address: liuy@tmu.edu.tw. |
| Source: | Neoplasia (New York, N.Y.) [Neoplasia] 2026 Jan; Vol. 71, pp. 101251. Date of Electronic Publication: 2025 Nov 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5586 (Electronic) Linking ISSN: 14765586 NLM ISO Abbreviation: Neoplasia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41176880 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dung+PVT%22">Dung PVT</searchLink>; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+WY%22">Chen WY</searchLink>; Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.<br /><searchLink fieldCode="AU" term="%22Liu+MK%22">Liu MK</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yeh+SD%22">Yeh SD</searchLink>; Department of Urology and Oncology, Taipei Medical University Hospital, Taipei 11031, Taiwan; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; Prostate Center of Excellence, Taipei Medical University Hospital, Taipei 11031, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kajla+G%22">Kajla G</searchLink>; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yeh+HL%22">Yeh HL</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+WH%22">Chen WH</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Jiang+KC%22">Jiang KC</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Li+HR%22">Li HR</searchLink>; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+CS%22">Chen CS</searchLink>; School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02215-5450, USA.<br /><searchLink fieldCode="AU" term="%22Wen+YC%22">Wen YC</searchLink>; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei 11031, Taiwan. Electronic address: 95207@w.tmu.edu.tw.<br /><searchLink fieldCode="AU" term="%22Liu+YN%22">Liu YN</searchLink>; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, New Taipei City 235, Taiwan; Prostate Center of Excellence, Taipei Medical University Hospital, Taipei 11031, Taiwan. Electronic address: liuy@tmu.edu.tw. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100886622%22">Neoplasia (New York, N.Y.)</searchLink> [Neoplasia] 2026 Jan; Vol. 71, pp. 101251. <i>Date of Electronic Publication: </i>2025 Nov 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100886622 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5586 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214765586%22">14765586 </searchLink><i>NLM ISO Abbreviation: </i>Neoplasia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41176880 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.neo.2025.101251 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101251 Titles: – TitleFull: A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dung PVT – PersonEntity: Name: NameFull: Chen WY – PersonEntity: Name: NameFull: Liu MK – PersonEntity: Name: NameFull: Yeh SD – PersonEntity: Name: NameFull: Kajla G – PersonEntity: Name: NameFull: Yeh HL – PersonEntity: Name: NameFull: Chen WH – PersonEntity: Name: NameFull: Jiang KC – PersonEntity: Name: NameFull: Li HR – PersonEntity: Name: NameFull: Chen CS – PersonEntity: Name: NameFull: Beltran H – PersonEntity: Name: NameFull: Wen YC – PersonEntity: Name: NameFull: Liu YN IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5586 Numbering: – Type: volume Value: 71 Titles: – TitleFull: Neoplasia (New York, N.Y.) Type: main |
| ResultId | 1 |